Employees: 02 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2002-06-28 (23 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CANNES (06400), Alpes-Maritimes
PHARMACIE DU CASINO : revenue, balance sheet and financial ratios
PHARMACIE DU CASINO is a French company
founded 23 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CANNES (06400),
this company of category PME
shows in 2022 a revenue of 1.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU CASINO (SIREN 695820589)
Indicator
2024
2023
2022
2021
2020
2019
2016
2015
2014
Revenue
N/C
N/C
1 252 195 €
1 137 466 €
682 793 €
1 442 212 €
1 168 341 €
1 113 058 €
1 113 911 €
Net income
147 813 €
94 848 €
-1 396 €
111 266 €
-19 921 €
8 808 €
27 820 €
311 972 €
-21 796 €
EBITDA
N/C
N/C
125 232 €
174 916 €
-32 124 €
53 304 €
36 531 €
47 393 €
32 775 €
Net margin
N/C
N/C
-0.1%
9.8%
-2.9%
0.6%
2.4%
28.0%
-2.0%
Revenue and income statement
In 2024, PHARMACIE DU CASINO generates positive net income of 148 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
147 813 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 34%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 57%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
34.291%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
56.627%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2014
2015
2016
2019
2020
2021
2022
2023
2024
Debt ratio
112.735
56.624
54.673
24.097
62.008
29.669
13.242
61.578
34.291
Financial autonomy
39.232
53.434
56.393
68.479
55.34
59.754
66.181
47.444
56.627
Repayment capacity
-53.806
13.641
14.814
5.114
-13.408
1.762
1.098
None
None
Cash flow / Revenue
-0.698%
2.807%
2.369%
2.981%
-5.348%
14.79%
9.593%
None%
None%
Sector positioning
Debt ratio
34.292024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good+11 pts over 3 years
In 2024, the debt ratio of PHARMACIE DU CASINO (34.29) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
56.63%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good-16 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DU CASINO (56.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
1.1 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Excellent
In 2022, the repayment capacity of PHARMACIE DU CASINO (1.10) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 227.47. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
227.466
Liquidity indicators evolution PHARMACIE DU CASINO
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2014
2015
2016
2019
2020
2021
2022
2023
2024
Liquidity ratio
40.234
205.478
89.828
141.378
329.825
176.545
203.303
219.295
227.466
Interest coverage
118.386
34.009
29.783
15.809
-22.211
2.635
2.847
None
None
Sector positioning
Liquidity ratio
227.472024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good+13 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DU CASINO (227.47) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
2.85x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Good
In 2022, the interest coverage of PHARMACIE DU CASINO (2.9x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU CASINO
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2014
2015
2016
2019
2020
2021
2022
2023
2024
Operating WCR
58 703 €
257 339 €
95 664 €
94 104 €
88 954 €
-46 864 €
57 413 €
0 €
0 €
Inventory turnover (days)
27
30
32
32
51
26
32
0
0
Customer payment term (days)
0
1
0
0
2
3
1
0
0
Supplier payment term (days)
41
48
31
27
60
74
43
0
0
Positioning of PHARMACIE DU CASINO in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DU CASINO is estimated at
2 063 578 €
(range 1 437 043€ - 3 087 231€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1437k€2063k€3087k€
2 063 578 €Range: 1 437 043€ - 3 087 231€
NAF 5 année 2024
Valuation method used
Net Income Multiple
147 813 €
×
14.0x
=2 063 579 €
Range: 1 437 044€ - 3 087 232€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU CASINO with other companies in the same sector:
Frequently asked questions about PHARMACIE DU CASINO
What is the revenue of PHARMACIE DU CASINO ?
The revenue of PHARMACIE DU CASINO in 2022 is 1.3 M€.
Is PHARMACIE DU CASINO profitable?
Yes, PHARMACIE DU CASINO generated a net profit of 148 k€ in 2024.
Where is the headquarters of PHARMACIE DU CASINO ?
The headquarters of PHARMACIE DU CASINO is located in CANNES (06400), in the department Alpes-Maritimes.
Where to find the tax return of PHARMACIE DU CASINO ?
The tax return of PHARMACIE DU CASINO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU CASINO operate?
PHARMACIE DU CASINO operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart